Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fujingshu tablets in chronic pelvic inflammatory disease
CTR20140207Phase 2Completed
- Sponsor
- Xi'an Tianrui Pharmaceutical Development Co., Ltd.
- Start
- May 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fujingshu Tablets in Pelviabdominal infection, sponsored by Xi'an Tianrui Pharmaceutical Development Co., Ltd.. Started May 2014; status: completed.
02
Drugs
Fujingshu Tablets
03
Conditions
Pelviabdominal infection
Beyond the preview
Go deeper on CTR20140207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140207.